How do you pay?

How to pay the least

Ask for the cash price

Kevzara

Kevzara is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Kevzara’s cash price, and one or two other pharmacies too.
  2. Kevzara’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameKevzara
Authorized genericsarilumab
Regular genericsarilumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Kevzara?
The original
–
–

Brand nameThe maker’s card

KevzaraConnect Copay Card

Savings card from Sanofi / Regeneron

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on kevzara.com 

Or call 1-844-538-9272.

In the maker’s words

“With the KevzaraConnect® Copay Card, eligible patients may pay as little as a $0 copay per month.”

From the maker’s offer on kevzara.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Kevzara itself, from the same company, sold without the brand name, and usually for less. For now Kevzara is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Kevzara is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

KEVZARA® is an interleukin-6 (IL-6) receptor antagonist indicated for treatment of:

  • adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs).
  • adult patients with polymyalgia rheumatica (PMR) who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper.
  • patients who weigh 63 kg or greater with active polyarticular juvenile idiopathic arthritis (pJIA).

Source: the FDA label for Kevzara (Sanofi-Aventis U.S. LLC), February 27, 2026. Full label on DailyMed 

Good to know